Where Can I Download My Heart Beats For Lola

[Orville Marquez]

PopeFrancis prays after receiving Communion during a memorial Mass for Pope Benedict XVI and the cardinals and bishops who have died over the past year celebrated at the Altar of the Chair in St. Peter's Basilica at the Vatican Nov. 3, 2023. (CNS photo/Lola Gomez)

"This is Christian humility, which is not simply one virtue among others, but the basic disposition of life: believing ourselves to be in need of God, making room for him and putting all our trust in him," the pope said in his homily Nov. 3.

The pope celebrated a memorial Mass in St. Peter's Basilica for Pope Benedict XVI and the six cardinals and 147 bishops who died over the past year. Eighteen of the bishops were from the United States and five were from Canada. Also included was Australian Cardinal George Pell, former prefect of the Vatican's Secretariat for the Economy, who died in January in Rome at the age of 81.

Pope Benedict, who died Dec. 31, 2022, reminded everyone "that faith is not primarily an idea to be understood or a moral precept to be followed, but a person to be encountered." Pope Francis said. "That person is Jesus Christ, whose heart beats with love for us, whose eyes look with pity upon our suffering."

The Lord is compassionate and "is moved by death, the greatest cause of our suffering," Pope Francis said. "How important it is to communicate that same look of compassion to all those who grieve for the death of their loved ones!" Pope Francis celebrates a memorial Mass for Pope Benedict XVI and the cardinals and bishops who have died over the past year at the Altar of the Chair in St. Peter's Basilica at the Vatican Nov. 3, 2023. (CNS photo/Lola Gomez)

"These are the people closest and dearest to the Lord," he said. "We cannot be close and dear to God if we ignore those who enjoy his protection and preferential love, for one day they will be the ones to welcome us to heaven."

"Indeed, Christians, especially the pope, the cardinals and the bishops, are called to be humble laborers: to serve, not to be served and to put the fruits of the Lord's vineyard before their own advantage," he said. "What a fine thing it is to renounce ourselves for the church of Jesus!"

With its Rome bureau founded in 1950, Catholic News Service has been providing complete, in-depth coverage of the popes and the Vatican for more than 70 years. CNS Rome continues to be your fair, faithful and informed connection to the Holy See.

The heart rate is the number of times the heartbeats per minute (BPM). According to the American Heart Association, a normal adult resting heart rate is between 60 beats per minute (BPM) and 100 BPM for people 15 years and older.

If a slow heart rate (bradycardia) only happens occasionally or is borderline, treatment may not be needed.

For people who are athletes or who are physically fit who have a slow heart rate, no treatment is needed.

In the last five years, more than ten UW Bothell students have gained real-world research experience in ISCRM labs and become part of a community of aspiring scientists from around the world.

Read More

A new gene therapy treatment for Duchenne muscular dystrophy (DMD) shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.

Read More

Kelly Stevens and Lola Eniola-Adefeso at the University of Michigan are co-leaders of a new NIH-funded center that will spur biomaterials translational solutions and bring together traditional, nontraditional, and historically excluded biomaterials researchers.

Read More

An NIH-funded collaboration involving ISCRM researchers has published a study describing how complementary areas of expertise produced new insights about hypertrophic cardiomyopathy at the protein, cell, and tissue levels.

Read More

For many years, efforts to remuscularize injured hearts have been stymied by engraftment arrhythmias that can cause the heart to beat too quickly. In a promising breakthrough, researchers in the Murry Lab have discovered a combination of gene edits that quelled the irregular heartbeats in lab animals. Listen to ISCRM Director Chuck Murry discuss the findings and what they could mean for patients in the future.

Want to learn more about stem cell and regenerative medicine? Visit our Learning Center to explore the science behind our research, the facts about stem cell therapy, and opportunities to engage with our faculty and students. // Learn More

The program launched in July 2023 thanks to generous philanthropic support from Lola C. Reinsch, who said: "I stepped forward to make this transformational gift in honor of the exceptional care I received when I faced my own life-changing heart condition just two years ago. Because of my personal health crisis, I was inspired to give what I could to advance heart care for other patients experiencing cardiomyopathies."

We develop and implement innovative, highly effective approaches to recognizing and treating cardiomyopathy at all stages of the disease through outstanding clinical care, research, and education to minimize complications from the disease and enhance the quality of life for cardiomyopathy patients in the Northern Virginia community and beyond. You can learn more about our work below.

We review and adapt risk stratification, prevention, detection, monitoring, and treatment protocols based on risk assessment algorithms, imaging and treatment guidance documents, and scientific statements from the American Heart Association, the American College of Cardiology, the Heart Rhythm Society, and the American Society for Echocardiography.

We establish and track measures of success, including the need for hospitalization, reduction in length of hospital stay, reduction in mortality, improved quality of life, and other relevant metrics, and document their outcomes.

Research is critical to guide future treatment decisions and policies. We focus on clinical research aimed at developing strategies to personalize and individualize therapies and treatments based on the unique characteristics and biology of the individual patient that will best improve their longevity and quality of life.

We provide funding for Investigator Initiated Studies to encourage innovative research and invite funding proposals from Inova Schar Heart and Vascular faculty for proof-of-concept studies which may go on for full funding by industry or government.

We are creating the Inova Reinsch Pierce Cardiomyopathy Program Registry, which is a state-of-the-art, highly functional clinical research database that will capture patient data on clinical demographics, including electrocardiograms, echocardiograms, results of the 6-Minute Walk Test, Chest X-Rays, cardiac Magnetic Resonance Imaging, and, importantly, DNA and biomarkers. We will also integrate the information into national and international collaborative cardiomyopathy registries so providers can follow patients throughout their lives.

We support research efforts to allow the testing of the potential efficacy of treatment options across the full spectrum of cardiovascular conditions in a broad range of patients through visionary genomic and biomarker studies.

Cardiomyopathies are progressive heart muscle conditions that make it harder for the heart to pump, caused by viral infections in the heart, genetic defects, coronary artery disease, arrhythmias and chemotherapy. They can lead to abnormal heart rhythms, heart failure, and backup of blood into the lungs or other parts of the body.

Though the exact prevalence of cardiomyopathies is unknown because they frequently go undiagnosed, as many as one in 500 adults may suffer from some form of cardiomyopathy, with rising numbers as the population ages. Types of cardiomyopathies include:

The most frequent form of cardiomyopathy, dilated cardiomyopathy, occurs when the left ventricle, the heart's main pumping chamber, is enlarged (dilated). As the chamber gets bigger, its thick muscular wall stretches, becoming thinner and weaker, affecting the heart's ability to pump enough oxygen-rich blood to the rest of the body.

Hypertrophic cardiomyopathy is the most common inherited or genetic heart disease, characterized by a thickening of the left ventricle muscle that blocks blood flow to the rest of the body and can sometimes affect the mitral valve, causing blood to leak backward through the valve. It can occur at many ages but often presents in childhood or early adulthood and can cause sudden death in adolescents and young adult athletes. Because there are frequently no symptoms, we screen patients with a family history to help with early diagnosis and prevent advanced disease or sudden death.

Restrictive cardiomyopathy (RCM) is a rare condition in which the heart's chambers stiffen, making it difficult for the heart to fill with blood properly. Though the heart has normal pumping function, it has difficulty relaxing between beats causing the upper chambers of the heart (atria) to enlarge while the lower chambers (ventricles) maintain their normal size. Eventually, the heart chambers can't properly fill with blood, which, in turn, backs up in the circulatory system. Other health conditions commonly cause RCM, but the cause can also be unknown (idiopathic).

RCMs are classified as primary (e.g., endomyocardial fibrosis, Lffler's endocarditis, idiopathic restrictive cardiomyopathy) or secondary, caused by infiltrative diseases such as amyloidosis (most common), sarcoidosis, radiation carditis, and storage diseases, such as hemochromatosis, glycogen storage disorders, and Fabry's disease.

It's an unfortunate truth that your body slows down in your sixth and seventh decades. Climbing a flight of stairs that you once took two at a time can now feel as daunting as scaling Mount Everest. While some degree of vitality loss can be attributed to natural aging, fatigue and breathlessness may also be signals that your heart is not functioning as well as it should.

3a8082e126